한글목차

세계의 맞춤형 유전체학 시장 규모는 2025년에는 125억 5,000만 달러로 추정되고, 2032년에는 381억 2,000만 달러에 이를 것으로 예측되며, 2025-2032년의 연간 평균 성장률(CAGR)은 17.2%를 나타낼 전망입니다.

맞춤형 유전체학은 유전학, 유전체학, 맞춤형 의료를 결합하고 개인의 유전적 체질에 대한 귀중한 인사이트를 제공하는 급성장 분야입니다.

시장 역학 :

세계의 맞춤형 유전체학 시장은 여러 요인들에 의해 견인되고 있습니다. 맞춤형 유전체학은 특정 질병의 발병 위험이 높은 개인을 식별하는 데 도움이 되며 조기 개입과 치명적인 치료를 가능하게합니다. 예를 들어, 2020년 9월, 만성 질환 예방에 게재된 기사에 따르면 2018년에는 기관에 입원하지 않은 민간인 성인 중 51.8%가 10개 중 1개 이상의 만성 질환을 진단받은 적이 있다고 합니다.

게다가 차세대 시퀀싱이나 바이오인포매틱스등의 기술의 진보에 의해 유전자 검사는 보다 친숙하고 저렴하게 되었습니다.

그러나 시장에는 일정한 억제요인도 존재합니다. 유전자 정보는 매우 민감하고, 적절하게 보호되지 않으면 악용될 가능성이 있기 때문에 프라이버시와 데이터 보안에 관한 우려가 제기되고 있습니다.

이러한 과제에도 불구하고 맞춤형 유전체학 시장에는 큰 기회가 있습니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 맞춤형 유전체학 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간 2025-2032년 시장 규모 및 CAGR을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 맞춤형 유전체학 시장 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형의 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 하고 있습니다.
• 이해관계자는 세계의 맞춤형 유전체학 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 맞춤형 의료 수요 증가와 R&D 투자 증가
  • 높은 비용과 복잡한 데이터 분석
  • 빅데이터와 인공지능 활용
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병과 인수 시나리오

제4장 세계의 맞춤형 유전체학 시장 : COVID-19 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 맞춤형 유전체학 시장 : 검사 유형별(2020-2032년)

• 종양학 검사
• 감염성 질환 검사
• 신경학 검사
• 심혈관 검사
• 기타

제6장 세계의 맞춤형 유전체학 시장 : 기술별(2020-2032년)

• PCR 기반 검사
• 마이크로어레이 기반 검사
• 시퀀싱 기반 검사
• 기타

제7장 세계의 맞춤형 유전체학 시장 : 용도별(2020-2032년)

• 진단
• 정밀의료
• 웰빙
• 생식보건
• 스포츠 영양 및 건강
• 라이프 스타일
• 기타

제8장 세계의 맞춤형 유전체학 시장 : 최종 사용자별(2020-2032년)

• 병원 및 진료소
• 연구센터
• 제약 및 바이오테크놀러지 기업
• 진단 실험실
• 기타

제9장 세계의 맞춤형 유전체학 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카
  • GCC 국가
  • 이스라엘
  • 남아프리카
  • 북아프리카
  • 중앙 아프리카
  • 기타 중동 및 아프리카

제10장 경쟁 구도

• 23andMe
• Mapmygenome
• Invitea
• Genetic Technology Limited
• Lonza
• Interleukin Genetics, Inc
• GNA Genotek
• Helix
• MyHeritage
• Pathway Genomics
• Veritas Genetics
• Xcode
• Color Genomics
• Myriad Genetics
• Quest Diagnostics
• Bio-Rad Laboratories, Inc.
• Illumina
• Thermo Fisher Scientific
• Qiagen
• Genomic Health
• Nebula Genomics

제11장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Personalized Genomics Market is estimated to be valued at USD 12.55 Bn in 2025 and is expected to reach USD 38.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.2% from 2025 to 2032.

Personalized genomics is a rapidly growing field that combines genetics, genomics, and personalized medicine to provide individuals with valuable insights into their genetic makeup.

Market Dynamics:

The global personalized genomics market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the need for personalized treatment options have created a demand for genetic testing services. Personalized genomics can help identify individuals who are at a higher risk of developing certain diseases, allowing for early intervention and targeted treatment. For instance, in September 2020, according to an article published in Preventing Chronic Disease, in 2018, 51.8% of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. More specifically, the 24.6% of adults have 1 chronic condition, and 27.2% have more than two chronic conditions.

Additionally, advancements in technology, such as next-generation sequencing and bioinformatics, have made genetic testing more accessible and affordable. This has led to a growing consumer base for companies offering personalized genomics services.

However, there are also certain restraints in the market. Concerns about privacy and data security have been raised, as genetic information is highly sensitive and can be misused if not properly protected. Regulatory challenges and the need for clear guidelines regarding the use and interpretation of genetic data also pose challenges to market growth.

Despite these challenges, the personalized genomics market presents significant opportunities. The integration of artificial intelligence and machine learning algorithms in genetic analysis can enhance the accuracy and efficiency of personalized genomics services. Additionally, the expansion of direct-to-consumer genetic testing and the increasing adoption of genetic testing in healthcare settings offer promising growth prospects for companies in this market.

Key features of the study:

• This report provides in-depth analysis of the global personalized genomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global personalized genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Personalized Genomics; 23andMe, Mapmygenome, Invitea, Genetic Technology Limited, Lonza, Interleukin Genetics, Inc, GNA Genotek, Helix, MyHeritage, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Myriad Genetics, Quest Diagnostics, Bio-Rad Laboratories, Inc., Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health, Nebula Genomics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global personalized genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized genomics market

Personalized Genomics Market Detailed Segmentation:

• By Test Type
  • Oncology Testing
  • Infectious Disease Testing
  • Neurological Testing
  • Cardiovascular Testing
  • Others
• By Technology
  • PCR-based Tests
  • Microarray-based Tests
  • Sequencing-based Tests
  • Others
• By Application
  • Diagnostics
  • Precision Medicine
  • Wellness
  • Reproductive Health
  • Sports Nutrition & Health
  • Lifestyle
  • Others
• By End User
  • Hospitals & Clinics
  • Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • 23andMe
  • Mapmygenome
  • Invitea
  • Genetic Technology Limited
  • Lonza
  • Interleukin Genetics, Inc
  • GNA Genotek
  • Helix
  • MyHeritage
  • Pathway Genomics
  • Veritas Genetics
  • Xcode
  • Color Genomics
  • Myriad Genetics
  • Quest Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • Genomic Health
  • Nebula Genomics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Personalized Genomics, By Test Type
  • Market Personalized Genomics, By Technology
  • Market Personalized Genomics, By Application
  • Market Personalized Genomics, By End User
  • Market Personalized Genomics, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing demand for personalized medicine and increase in R&D investments
  • High costs and complex data interpretation
  • Leveraging Big Data and Artificial Intelligence
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Personalized Genomics Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Personalized Genomics Market, By Test Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Oncology Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Infectious Disease Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Neurological Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cardiovascular Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Personalized Genomics Market, By Technology, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• PCR-based Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Microarray-based Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Sequencing-based Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

7. Global Personalized Genomics Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Precision Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Wellness
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Reproductive Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Sports Nutrition & Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Lifestyle
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Global Personalized Genomics Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Research Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

9. Global Personalized Genomics Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • South Africa
    • North Africa
    • Central Africa
    • Rest of Middle East

10. Competitive Landscape

• 23andMe
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mapmygenome
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Invitea
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genetic Technology Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Interleukin Genetics, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GNA Genotek
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Helix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• MyHeritage
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pathway Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Veritas Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Xcode
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Color Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Myriad Genetics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Quest Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Qiagen
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genomic Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nebula Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us